uniQure has announced positive topline results from its pivotal Phase I/II trial of AMT-130 for the...
Author - Abby Davey
Pioneering TIL Therapy Delivered for Metastatic Lung Cancer at...
HCA Healthcare UK has delivered its first Tumour-Infiltrating Lymphocyte (TIL) therapy for a...
Lilly launches TuneLab to accelerate AI-driven drug discovery...
Eli Lilly and Company has launched Lilly TuneLab, an artificial intelligence and machine learning...
Koselugo Recommended for EU Approval in Adults with NF1...
AstraZeneca’s Koselugo (selumetinib) has secured a positive recommendation from the European...
SAR446268 Earns US Fast Track Designation for Non-Congenital...
Sanofi is pleased to announce that the US Food and Drug Administration (FDA) has granted Fast Track...
Enhertu plus pertuzumab granted FDA Priority Review as potential...
AstraZeneca and Daiichi Sankyo have announced that the US Food and Drug Administration (FDA) has...
Johnson & Johnson Reports Positive Phase 3 Results for...
Johnson & Johnson has released new Phase 3 clinical trial data showing that icotrokinra, a...
Sanofi’s Brivekimig Shows Positive Phase 2a Results in...
Sanofi has reported encouraging Phase 2a data for brivekimig, a dual-target Nanobody® molecule...
Pfizer and BioNTech Report Strong Immune Response from LP.8.1...
Pfizer and BioNTech have announced topline Phase 3 clinical trial data showing a robust immune...
Nutrien to Divest 50% Equity Stake in Profertil S.A. for US$600...
Nutrien Ltd. has announced an agreement to sell its 50 percent equity stake in Argentina-based...